BioCrossroads

More life sciences firms opt to launch products in EuropeRestricted Content

July 30, 2011
Maria LaMagna
The U.S. Food and Drug Administration's growing reputation for unpredictability is spurring some Indianapolis companies to join counterparts elsewhere and introduce products in Europe. The upshot is that some Americans may never benefit from innovations occurring in their backyards.
More

Indiana life sciences leaders look toward the futureRestricted Content

July 30, 2011
Chris O'Malley
Former Eli Lilly and Co. vice president Richard Dimarchi, BioCrossroads President David Johnson, angel investor Oscar Moralez and Purdue University Senior Vice President Alan Rebar discuss issues ranging from the depth of the life sciences industry in Indiana to venture capital and Purdue's Discovery Park.
More

Tech district could boost Indianapolis' convention businessRestricted Content

July 23, 2011
Scott Olson
The Indianapolis Convention & Visitors Association plans to attract more life sciences conferences.
More

Report: State's life science sector continues to grow

June 23, 2011
Chris O'Malley
A total of 220 life sciences startups have been launched in Indiana since 2004, or an average of 44 per year, according to a new report from BioCrossroads that tracked the industry’s growth over the last eight years.
More

Lilly licenses Xigris rights to new biotech firm

May 23, 2011
J.K. Wall
Eli Lilly and Co. has agreed to license the U.S. marketing rights of its slow-selling sepsis drug Xigris to a newly created local biotech company called BioCritica that will seek to reinvigorate sales of the medication.
More

BISHOP: Warsaw's orthopedics whizzes will master biologicsRestricted Content

May 14, 2011
Industry cluster in northern Indiana has adapted to every other change in health care, and will absorb tissue regeneration, too.
More

Indianapolis bio sector hopeful as venture firms cash outRestricted Content

April 30, 2011
Chris O'Malley
Profits flowing from earlier investments could mean more available capital, but firms continue to be selective in placing their bets.
More

Marcadia Biotech principals ponder next course

March 22, 2011
Chris O'Malley
Marcadia execs French, Hawryluk reflect on massive growth of Carmel firm after sale to Roche.
More

Franciscan's electronic records rollout shows industry growth

February 23, 2011
J.K. Wall
Franciscan Alliance will spend more than $100 million over the next two years to install a common electronic medical record system at its 13 hospitals and more than 165 physician practices. It’s a sign of the growth of the health information technology industry in Indiana, which a new BioCrossroads report says generates $200 million a year in sales and is growing at 8 percent annually.
More

Roche acquires Marcadia Biotech

December 30, 2010
Chris O'Malley
Marcadia Biotech Inc., a Carmel-based biopharmaceutical company founded by prominent scientists from Eli Lilly and Co. in 2006, has been acquired by Swiss life sciences giant Roche.
More

Indiana Seed Fund makes 11th investment

December 23, 2010
 IBJ Staff
A $250,000 investment in Aarden Pharmaceuticals will go toward advancing tuberculosis therapy through the pre-clinical development stage.
More

Lilly Endowment gives $35M to start pharmacy school

December 20, 2010
J.K. Wall
Manchester College will use money to launch the state's third program offering doctorates in pharmacy.
More

State adds record number of life sciences jobs

December 11, 2010
 IBJ Staff
Twenty companies committed this year to add more than 4,000 jobs.
More

Indiana life sciences upstarts tap health reform booty

November 6, 2010
 IBJ Staff
The federal legislation is roundly criticized at a BioCrossroads meeting, but some firms have found a silver lining.
More

Indiana's life sciences industry sees trouble ahead

October 30, 2010
Associated Press
Indiana's life sciences industry has weathered the recession relatively well, but Eli Lilly's struggles and tight capital markets could threaten the future.
More

BioCrossroads helping laid-off life sciences workers land safely

October 30, 2010
Chris O'Malley
Indiana firms have dismissed more than 1,400 life science workers over the last two years. Now BioCrossroads has launched a website that aims to keep that talent in the state.
More

Indiana life sciences sector copes with shrinking VC poolRestricted Content

October 30, 2010
Chris O\'malley
Venture funds nationwide crested at $100 billion in 2000, but that number last year had drooped to $18 billion.
More

Endocyte's $86M IPO plan a boon for Indiana, investors

August 28, 2010
Greg Andrews
Venture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital, Clarian Health Ventures and the Indiana Future Fund.
More

Indiana Seed Fund nearing end of $6 million stashRestricted Content

June 5, 2010
Chris O'Malley
Having invested in 10 companies since 2005 and with its $6 million pot of money running low, the Indiana Seed Fund is nearing a crossroads.
More

OrthoWorx initiative names executive director

June 3, 2010
 IBJ Staff
Not-for-profit launched last year by BioCrossroads and Indiana's orthopedic companies names Zimmer Inc. executive Brad Bishop to lead the initiative.
More

Indianapolis startup attacks Alzheimer's diseaseRestricted Content

May 29, 2010
Norm Heikens
AgeneBio Inc. this month landed a $300,000 investment from the Indiana Seed Fund to fund operations, bolster its intellectual property, and begin learning how to make a drug into a once-a-day pill.
More

Indiana's growth in life sciences jobs beats national average

May 8, 2010
 IBJ Staff
Bloomington led the nation as the No. 1 small city in medical devices and equipment.
More

Chao exit hurts drug development industry

April 28, 2010
J.K. Wall
Purdue University’s decision to close the Chao Center in West Lafayette is a setback for Indiana’s effort to grow a vibrant contract drug manufacturing sector. But it’s just the latest in a series of unexpected changes—not all for the worse—since Indianapolis-based BioCrossroads launched a contract drug manufacturing initiative in late 2007.
More

Indiana companies that serve pharmaceutical industry grew in 2009

February 20, 2010
 IBJ Staff
The firms continued to grow over the last year but face increasing challenges, according to a new report by Indianapolis-based life sciences trade group BioCrossroads.
More

Report: State's pharmaceutical contractors continue to grow

February 10, 2010
A report set to be released Wednesday by local life sciences industry group BioCrossroads says Indiana companies providing contract pharmaceutical research and manufacturing services are weathering the economic downturn and are growing.
More
Page  << 1 2 3 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Those of you yelling to deport them all should at least understand that the law allows minors (if not from a bordering country) to argue for asylum. If you don't like the law, you can petition Congress to change it. But you can't blindly scream that they all need to be deported now, unless you want your government to just decide which laws to follow and which to ignore.

  2. 52,000 children in a country with a population of nearly 300 million is decimal dust or a nano-amount of people that can be easily absorbed. In addition, the flow of children from central American countries is decreasing. BL - the country can easily absorb these children while at the same time trying to discourage more children from coming. There is tension between economic concerns and the values of Judeo-Christian believers. But, I cannot see how the economic argument can stand up against the values of the believers, which most people in this country espouse (but perhaps don't practice). The Governor, who is an alleged religious man and a family man, seems to favor the economic argument; I do not see how his position is tenable under the circumstances. Yes, this is a complicated situation made worse by politics but....these are helpless children without parents and many want to simply "ship" them back to who knows where. Where are our Hoosier hearts? I thought the term Hoosier was synonymous with hospitable.

  3. Illegal aliens. Not undocumented workers (too young anyway). I note that this article never uses the word illegal and calls them immigrants. Being married to a naturalized citizen, these people are criminals and need to be deported as soon as humanly possible. The border needs to be closed NOW.

  4. Send them back NOW.

  5. deport now

ADVERTISEMENT